Search Results 8511-8520 of 42474 for oral

1. A Rollover Study To Further Evaluate The Safety And Efficacy Of Palovarotene Capsules In Male And Female Participants Aged ≥ 14 Years With Fibrodysplasia Ossificans Progressiva (FOP) Who Have Completed The Relevant Parent Studies. - Mayo Clinic

   of these products during palovarotene treatment. - Exposure to synthetic oral retinoids other than palovarotene within 4 weeks of the. Inclusion Visit ...

2. Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors - Mayo Clinic

   oral TNG908 6. Active prior or concurrent malignancy. 7. Central nervous system metastases associated with progressive neurological symptoms 8. Current ...

3. A Study to Evaluate RheOx Bronchial Rheoplasty System to Treat Chronic Bronchitis in Adults with COPD - Mayo Clinic

   mycobacterium avium-intracellulare infection (MAI), fungus, tuberculosis). 2. Patient has a steroid-dependent condition requiring >10 mg of oral corticosteroid ...

4. Diabetic nephropathy (kidney disease) - Doctors and departments - Mayo Clinic

   Research at Mayo Clinic in diabetic nephropathy includes developing new diagnostic and treatment tools, such as oral medicines that may help stop or delay ...

5. Treatment For CI-DME In Eyes With Very Good VA Study - Mayo Clinic

   Current regular use of oral anti-hyperglycemia agents for the treatment of diabetes; Documented diabetes by American Diabetes Association (ADA) and/or World ...

6. Tongue cancer - Doctors and departments - Mayo Clinic

   Investigating tumor growth factors for oral cancer. Evaluating new methods of use for chemotherapy. Evaluating new radiation therapy regimens. Investigating the ...

7. Tongue cancer - Doctors and departments - Mayo Clinic

   Investigating tumor growth factors for oral cancer. Evaluating new methods of use for chemotherapy. Evaluating new radiation therapy regimens. Investigating ...

8. Idasanutlin, Ixazomib Citrate, And Dexamethasone In Treating Patients With Relapsed Multiple Myeloma - Mayo Clinic

   ... oral absorption or tolerance of ixazomib or idasanutlin including difficulty swallowing; Diarrhea > grade 1, based on the National Cancer Institute (NCI) ...

9. A Study of GDC-0449 and Erlotinib Hydrochloride, with or without Gemcitabine Hydrochloride for Treating Patients with Metastatic Pancreatic Cancer or Solid Tumors that cannot be Removed by Surgery - Mayo Clinic

   Oral contraception containing progestins only; IUD progesterone T; Female condom; Natural family planning (rhythm method) or breastfeeding; Fertility awareness ...

10. A Phase II Study of the Anti-PD1 Antibody Pembrolizumab (MK-3475) in Patients With Advanced Sarcomas - Mayo Clinic

    Patients with a history of non-infectious pneumonitis that has required a course of oral or intravenous steroids to assist with recovery, or interstitial lung ...